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Abstract
Background: Mice expressing fluorescent proteins in neurons are one of the most powerful tools in modern neuroscience
research and are increasingly being used for in vivo studies of neurodegeneration. However, these mice are often used
under the assumption that the fluorescent proteins present are biologically inert.
Methodology/Principal Findings: Here, we show that thy1-driven expression of yellow fluorescent protein (YFP) in neurons
triggers multiple cell stress responses at both the mRNA and protein levels in vivo. The presence of YFP in neurons also
subtly altered neuronal morphology and modified the time-course of dying-back neurodegeneration in experimental
axonopathy, but not in Wallerian degeneration triggered by nerve injury.
Conclusions/Significance: We conclude that fluorescent protein expressed in thy1-YFP mice is not biologically inert,
modifies molecular and cellular characteristics of neurons in vivo, and has diverse and unpredictable effects on
neurodegeneration pathways.
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Introduction
The development of transgenic mice endogenously expressing
spectral variants of fluorescent proteins such as GFP, YFP and
CFP (collectively termed XFPs) in neurons, under the control of
the neuronal-specific thy1 gene, has revolutionised modern
neuroscience research, facilitating experimental breakthroughs
and revolutionising our understanding of the form and function
of the nervous system in health and disease [1–8]. Early studies
on thy1-XFP mice reported that expression of fluorescent proteins
in neurons had no discernable effect on neuronal morphology or
any detectable level of toxicity [1], in agreement with earlier
reports suggesting that XFPs are biologically inert [9]. Thus,
there is an underlying assumption that the presence of fluorescent
protein has no effect on the cellular or molecular composition of
neurons in vivo. However, neurons in these mice contain large
amounts of a foreign fluorescent protein. Such fluorescent
proteins are known to be capable of altering the cellular and
molecular characteristics of living cells in other experimental
model systems in vivo and in vitro (e.g. the cardiovascular system),
triggering stress responses and pathological changes [10–11].
Given the ever-increasing use of thy1-XFP mice for not only
cellular, but also molecular, experiments in the healthy and
pathological nervous system, a thorough investigation of the
consequences of XFP expression in neurons of these mice is
required.
Results and Discussion
We initially tested whether expression of yellow fluorescent
protein modifies neuronal cell stress pathways in thy1-YFP line 16
(YFP-16) mice in vivo. YFP-16 mice from our breeding colony
(founders originally purchased from Jackson Laboratories)
appeared identical to those previously reported in the literature,
expressing YFP in the vast majority of neurons in the peripheral
nervous system [1]. We used cell stress pathway-specific RT2
profiler PCR arrays to quantify and compare expression of
known cell stress-related genes in the spinal cord of thy1-YFP line
16 (YFP-16) mice on a C57Bl/6 background compared to wild-
type C57Bl/6 controls from the same breeding colony.
Surprisingly, half of all the cell stress genes (41 out of 84) on
the PCR array were up-regulated more than 1.5-fold in spinal
cord from YFP-16 mice (Figure 1A; Table 1). Of these, several
had expression levels increased more than 2-fold, including genes
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involved in cell stress activation, inflammation and apoptosis
(Table 1). None of the genes on the array were found to be
significantly down-regulated .1.5 fold in YFP-16 mouse spinal
cord (Figure 1A).
To confirm that the RNA changes observed in YFP-16 mouse
spinal cord resulted in corresponding changes at the protein level,
expression levels for 2 proteins selected from the PCR array
(caspase 1 and CCL3) were validated in YFP-16 mouse spinal cord
using quantitative fluorescent western blot (Figure 1B,C). Expres-
sion levels of another cell stress protein not included on the array -
stress inducible protein 1 (STI1) – remained unchanged in YFP-16
tissue, showing that not all cell stress proteins responded to the
presence of YFP (Figure 1B,C). Increased expression of caspase 1
correlated directly with the amount of YFP present, as levels in
YFP-16 mouse spinal cord were 70-fold higher than levels in YFP-
H mice where YFP is only expressed in a minority of neurons
(Figure 1D,E) [1]. Importantly, immunohistochemistry for caspase
1 expression in YFP-H mouse spinal cord confirmed that
increased cell stress responses were restricted to neuronal cells
expressing YFP (Figure 1F–I). Taken together, these data
demonstrate that expression of YFP in mouse neurons in vivo
activates a robust, but selective, cell stress response at both the
RNA and protein level.
We next sought to establish whether activation of cell stress
pathways in YFP-expressing neurons had any adverse effects on
neuronal morphology. We examined lower motor neurons
innervating the levator auris longus muscle in YFP-H mice,
allowing us to directly compare the morphology of YFP-expressing
neurons with neighbouring non-expressing neurons in the same
muscles from individual animals (Figure 2A). As previously
reported [1], all neuromuscular junctions in 2–4 month old
YFP-H mice were fully innervated by a single motor axon
collateral (Figure 2A). However, higher-resolution analysis re-
vealed a significant increase in abnormal accumulations of
neurofilaments in distal axons and motor nerve terminals when
YFP was present. This morphology is similar to cytoskeletal
changes considered to represent early pathological changes in
neurons [3,12] (Figure 2B–E). Neurofilament accumulations
greater than a score of 1 on our 0–5 accumulation ranking scale
were very rarely observed in distal axons and motor nerve
terminals innervating the entire levator auris longus muscle in
wild-type mice (data not shown). This reduces the likelihood that
the neurofilament accumulations we observed in YFP-expressing
neurons reflected an underlying biological diversity in neurofila-
ment distribution between motor neuron pools that may or may
not be selectively labelled in YFP-H mice. Retrospective
examination of banked tissue from a now defunct YFP-16 mouse
colony with very high YFP expression levels (,7 times greater
than those found in our standard YFP-16 colony) revealed more
severe morphological abnormalities, suggesting a dose-dependent
effect (Figure 3).
It has previously been suggested that modulation of cell stress
pathways can alter the response of neurons to neurodegenerative
stimuli [13–14]. Therefore, we next addressed whether the
presence of YFP in neurons also affected neurodegeneration
pathways in vivo. YFP protein persists and retains its fluorescent
properties in degenerating neurons, and has previously been used
to visualise the breakdown of axons and synapses in a range of
different models of neurodegeneration [3–5,15]. The rapid
instigation (within 20 hours of nerve lesion), and morphological
correlates, of Wallerian degeneration following nerve lesion were
not altered in YFP-expressing motor neurons (Figure 2F–G).
However, in wasted mice, where loss of the translation elongation
factor eEF1A2 causes a severe distal axonopathy [15], the majority
of YFP-expressing neurons remained intact whilst neighbouring
non YFP-expressing neurons were in the final stages of
degeneration, even at late-symptomatic ages (Figure 2H–L).
Therefore, the severity of dying-back pathology, which is
mechanistically distinct from Wallerian degeneration [15], was
significantly modified in YFP-expressing motor neurons from
wasted mice.
In conclusion, our finding that expression of YFP in neurons
instigates cell stress pathways means that fluorescent protein
expressed in neurons from thy1-YFP mice is not biologically inert.
This finding provides importance evidence, supported by data
from other in vivo and in vitro experimental systems [10–11,16–17],
that fluorescent proteins expressed in cells/tissues can modify their
molecular composition and cellular activities. Care must now be
taken with regard to experimental design and data interpretation,
particularly when investigating molecular mechanisms of neuro-
degeneration in mice endogenously expressing fluorescent protein
in neurons. Future studies must take into account the modified
molecular characteristics and altered phenotypic responses
observed here and perform necessary controls to ensure that any
responses they are reporting are a direct result of experimental
intervention rather than simply a consequence of the expression of
fluorescent protein.
Materials and Methods
Ethics statement
All animal experiments were approved by a University of
Edinburgh internal ethics committee and were performed under
license by the UK Home Office (project license number 60/3891).
Mice
Breeding colonies of thy1-YFP-H mice [1] and thy1-YFP-16
mice, both on a C57BL/6J background, were originally
purchased as breeding pairs from Jackson Laboratories and
established and maintained in animal care facilities (standard SPF
conditions) at the University of Edinburgh. Wild-type C57Bl/6J
mice (not expressing YFP protein) from the same breeding colony
Figure 1. YFP expression activates cell stress responses in neurons in vivo. A – 3D bar chart showing fold-differences in mRNA expression
levels for 84 cell stress related genes comparing spinal cord from YFP-16 mice with wild-type mice (N= 3 samples, each consisting of pooled tissue
from 3 mice). Note that we only observed increased expression of cell stress related genes. B – Representative fluorescent western blots for cell stress
proteins in the spinal cord of wild-type and YFP-16 mice. Both caspase 1 (Casp1) and CCL3 had increased expression in YFP-expressing tissue,
whereas STI1 (a stress protein not on the array) remained at the same levels found in wild-type mice and YFP (FP) was only present in YFP-16 tissue.
C - Bar chart (mean6 s.e.m.) showing quantification of protein expression levels in YFP-16 spinal cord (normalised to wild-type: fluorescence intensity
ratio of 1 = identical to wild-type), confirming increased expression levels of CCL3 and caspase 1 (N= 3 samples, each consisting of pooled tissue from
3 mice). D/E - Representative fluorescent western blots and bar chart showing caspase 1 expression in the spinal cord of wild-type, YFP-H (low YFP
expression) and YFP-16 (high YFP expression) mice. Increased levels of caspase 1 correlated with the amount of YFP present. F-I - Representative
confocal micrographs showing caspase 1 immunohistochemistry (red = caspase 1; yellow=YFP; blue= TO-PRO) in the spinal cord of a YFP-H mouse.
Increased caspase 1 immunolabelling was restricted to YFP-positive neurons. Scale bar = 20 mm.
doi:10.1371/journal.pone.0017639.g001
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were used for controls throughout. Mice were sacrificed by
inhalation of isofluorane (2% in 1:1 N2O/O2). All procedures
were carried out under licensed authority from the UK Home
Office. The YFP status of mice was ascertained by examining ear
punches for YFP-positive neurons. To determine the effects of
YFP expression on dying-back pathology, YFP-H mice were
crossed with wasted mice [15]. Wasted/YFP-H mice were
genotyped using standard PCR techniques, as described previ-
ously [15], and were taken for analysis at post-natal day 24 (late-
symptomatic). The banked tissue from a previous, now defunct,
colony of strongly-expressing thy1-YFP-16 mice was obtained
from mice originally supplied to the University of Leeds by
Jackson Laboratories.
Cell stress array
Mouse cell stress focused pathway arrays in a 96-well plate
format (PAM-003A), compatible with an ABI 7000 real-time PCR
machine, were used to assay cell stress gene expression (3
comparisons for YFP-16 and 3 for wild-type controls, each
comparison composed of pooled whole spinal cord tissue from 3
individual 2 month old mice). RNA was extracted as previously
described [14]. Samples were added to the reaction plate and
signal amplification by PCR was carried out using Sybr-Green ‘1
step qRT-PCR kit’ (Invitrogen). Analysis was carried out using the
Analysis Suite spreadsheet provided by Tebubio SuperArrays.
Gene functions listed in Table 1 were obtained from the
SuperArray product specification sheets.
Quantitative fluorescent (Li-COR) western blots
Total protein was isolated from spinal cords and quantitative
western blots were performed as described previously [18–20].
Primary antibodies were used as per manufacturers instructions
(STI1 – BD Biosciences; Caspase 1 and CCL3 – Abcam; GFP -
Millipore). Odyssey secondary antibodies were used in accordance
with manufacturers instructions (Goat anti mouse IRDye 680 and
Goat anti rabbit IRDye 680). Blots were imaged using an Odyssey
Infrared Imaging System (Li-COR Biosciences). Quantification
was performed on single channels with the analysis software
provided. Bands were identified according to their molecular
weight and the arbitrary fluorescence intensity was calculated by
Odyssey software.
Spinal cord immunohistochemistry
Entire vertebral columns were removed and immediately
immersed in 4% paraformaldehyde solution for 1 hour. Spinal
cords were removed from the vertebral column and fixed for a
further 30 mins before embedding in 2% low-melting point
agarose. Embedded spinal cords were mounted on a vibratome
and transverse sections cut at a thickness of ,200 mm for
immunohistochemical staining. Sections were blocked in 4%
bovine serum albumin (BSA) and 1.5% TritonX in 0.1 M PBS for
30 minutes before incubation in primary antibodies directed
against caspase 1 (1:500 dilution; Abcam) overnight. After washing
for 2 hours in 0.1 M PBS, sections were incubated for 2 hours in a
1:30 dilution of swine anti-rabbit TRITC-conjugated secondary
antibody (Dako). Sections were co-stained with the nuclear dye
TOPRO-3 (Molecular Probes), whole-mounted in MowoilH
(Calbiochem) on glass slides and cover-slipped for subsequent
imaging.
Surgery
Mice were anaesthetised by inhalation of halothane (2% in 1:1
N2O/O2) before exposing the intercostal nerves innervating the
transversus abdominis muscle. Nerves were cut before suturing the
skin and allowing the mouse to recover for 20 hours. Post-
operative mice were maintained in standard animal house
conditions.
Table 1. Mouse SuperArray data showing greater than 1.5
fold cell stress RNA expression changes in the spinal cord of
YFP-16 mice compared with wild-type controls (*array cell
refers to the location on the 3D bar chart in Fig. 1A).
Array cell* Symbol Fold change Role in cell stress
A09 Ccl4 3.26 Inflammation
C03 Cyp7a1 3.14 Oxidative or metabolic stress
A08 Ccl3 2.94 Inflammation
B04 Csf2 2.77 Inflammation
A05 Casp1 2.30 Apoptosis signalling
F06 Nfkbia 2.26 Apoptosis signalling
B11 Cyp2c29 2.23 Oxidative or metabolic stress
F01 Lta 2.18 Inflammation
A06 Casp8 2.11 Apoptosis signalling
B02 Chek2 2.07 DNA damage and repair
A01 Anxa5 1.95 Apoptosis signalling
A07 Ccl21b 1.94 Inflammation
C01 Cyp4a10 1.93 Oxidative or metabolic stress
G05 Tnfsf10 1.92 Apoptosis signalling
D05 Gpx2 1.90 Oxidative or metabolic stress
A03 Bax 1.89 Apoptosis signalling
B05 Cxcl10 1.84 Inflammation
D09 Hmox1 1.84 Oxidative or metabolic stress
B10 Cyp2b9 1.84 Oxidative or metabolic stress
F07 Nos2 1.79 Inflammation
D08 Gstm3 1.79 Oxidative or metabolic stress
B06 Cyp1a1 1.74 Oxidative or metabolic stress
F02 Mdm2 1.72 Growth arrest and senescence
C07 Egr1 1.72 Proliferation and carcinogenesis
C04 Ddit3 1.68 Growth arrest and senescence
F12 Rad50 1.67 DNA damage and repair
A02 Atm 1.66 DNA damage and repair
E11 Il1b 1.65 Inflammation
C02 Cyp4a14 1.64 Oxidative or metabolic stress
H01 Gusb 1.63 Oxidative or metabolic stress
B07 Cyp1b1 1.63 Oxidative or metabolic stress
G08 Ugt1a2 1.63 DNA damage and repair
C12 Fmo1 1.62 Oxidative or metabolic stress
A04 Bcl2l1 1.62 Apoptosis signalling
E02 Hspa4 1.60 Heat Shock
A11 Ccnd1 1.59 Proliferation and carcinogenesis
B03 Cryab 1.56 Oxidative or metabolic stress
B09 Cyp2b10 1.56 Oxidative or metabolic stress
B12 Cyp3a11 1.56 Oxidative or metabolic stress
F11 Rad23a 1.52 DNA damage and repair
G04 Tnfrsf1a 1.52 Apoptosis signalling
doi:10.1371/journal.pone.0017639.t001
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Immunohistochemical analysis of axons and
neuromuscular junctions
The levator auris longus (LAL) [21–22] and/or transversus
abdominis (TVA) [12] muscles and their nerve supply were
dissected and fixed in 0.1 M PBS containing 4% paraformalde-
hyde (Electron Microscopy Science) for 10 minutes. YFP tissue
was additionally double-labelled by exposure to a-bungarotoxin
conjugated to Alexa FluorH 647 (Alexa 647-a-BTX; 5 mg/ml,
Invitrogen) for 30 minutes to label post-synaptic acetylcholine
receptors. Muscles were blocked in 4% bovine serum albumin
(BSA) and 1.5% TritonX in 0.1 M PBS for 30 minutes before
incubation in primary antibodies directed against 145 kDa
neurofilament proteins (1:300 dilution; Millipore) overnight to
label axons and nerve terminals. After washing for 2 hours in
0.1 M PBS, muscles were incubated for 4 hours in a 1:30
dilution of swine anti-rabbit TRITC-conjugated secondary
antibody (Dako). Muscles were whole-mounted in MowoilH
(Calbiochem).
Microscopy
Fluorescently labelled axon and nerve/muscle preparations
were viewed using a laser scanning confocal microscope (636
objective; 1.4NA; Zeiss LSM 710). Confocal Z-series were
merged using Zeiss software and images assembled for analysis
using Adobe Photoshop. All images were taken using sequential
laser capture and with the excitation/emission spectra set to
ensure no bleed-through between channels. A minimum of 50
neuromuscular junctions, selected at random, were assessed in
each muscle preparation. Quantitative analysis was performed on
micrographs with the YFP channel initially excluded, so that the
operator did not know the YFP status of the tissue being analysed.
For analysis of neurofilament accumulation in normal tissue,
endplates were qualitatively assigned a score between 0 and 5,
with 0 representing healthy neuromuscular junctions with no
evidence of neurofilament accumulation and 5 representing nerve
terminals with large abnormal accumulations of neurofilament.
The YFP channel was revealed subsequent to quantification to
Figure 2. YFP expression in motor neurons subtly disrupts normal neuronal morphology and alters responses to dying-back
pathology but not Wallerian degeneration. A–D – Representative confocal micrographs of NMJs in the levator auris longus muscle from a YFP-
H mouse labelled for neurofilaments (NF: red) and postsynaptic motor endplates (BTX: blue). Note that all motor endplates were innervated, but only
a small proportion of motor axons were YFP-positive in these mice (A). Panels B–D show high power micrographs of NMJs identified in panel A. Note
abnormal accumulations of NF only in the motor nerve terminals of YFP-positive NMJs (B =NF accumulation score of 0, C = 3, D = 5). E – Bar chart
(mean 6 s.e.m.) showing quantification of NF accumulation in motor nerve terminals from YFP-H mice (0 = no accumulation; 5 = large abnormal
accumulation), revealing a significant increase in NF accumulation in YFP-positive terminals (N = 5 mice, n = 9 muscles; *** P,0.001 Mann-Whitney
test). F–G – Representative confocal micrographs of intramuscular axons supplying the transversus abdominis muscle from YFP-H mice (also labelled
for NFs; red), before (F) and 20 hours after (G) intercostal nerve lesion. The presence of YFP did not alter the rate or morphological appearance of
Wallerian degeneration after nerve injury, with NF fragmentation occurring in YFP-positive and –negative axons in all nerves examined (N= 6 mice,
n = 6 nerves). H–K - Representative confocal micrographs of two NMJs in the levator auris longus muscle from a late-symptomatic (P24) wasted/YFP-H
mouse labelled to reveal NFs (red) and postsynaptic motor endplates (BTX: blue). Note how the motor axon with YFP (bottom NMJ) remained intact
whereas the motor axon without YFP (top) was undergoing retraction, characteristic of a dying-back pathology. L - Bar chart showing quantification
of dying-back pathology at the NMJ in late-symptomatic (P24) wasted/YFP-H mice, revealing a significant attenuation of dying-back pathology in
motor nerve terminals where YFP was present (i.e. a retention of endplates fully occupied by overlying NFs and a reduction in the numbers of
partially occupied endplates; N = 4 mice, n = 7 muscles; *** P,0.001 Mann-Whitney test). Scale bars = 80 mm (A), 40 mm (B–D), 30 mm (F–G), 50 mm
(H–K).
doi:10.1371/journal.pone.0017639.g002
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determine the YFP status of each nerve terminal. For occupancy
counts in Wasted/YFP-H mice undergoing dying-back pathology,
endplates were categorised as either partially occupied (neurofil-
ament partially overlying the endplate) or fully occupied
(neurofilament entirely overlying the endplate). Vacant endplates
were excluded from analysis since there was no way to establish
their original YFP status.
Statistical analysis
All data were collected into Microsoft Excel spreadsheets and
analysed using GraphPad Prism software. All bar charts shown are
mean6 s.e.m. Statistical significance was considered to be p,0.05
for all analyses. Individual statistical tests used are detailed in
figure legends.
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